臨床外科79巻9号

2024年09月発行

特集 徹底解説　大腸癌治療ガイドライン2024

詳説

肛門管扁平上皮癌に対する化学放射線療法

著者： 室伏景子¹

所属機関： ¹東京都立駒込病院放射線治療科

ページ範囲：P.1034 - P.1039

文献概要

【ポイント】
◆肛門管扁平上皮癌に対する標準治療は，高い無人工肛門造設生存率を期待できる化学放射線療法である．
◆至適な併用化学療法はフルオロウラシル（5-FU^®）＋マイトマイシンC（MMC）であり，MMCが使用できない場合には，代替役としてシスプラチン（CDDP）の使用が許容される．
◆放射線治療による消化管の有害事象低減を目的に，照射時の蓄尿や強度変調放射線治療（IMRT）により消化管の照射体積低減を図る．

参考文献

1）Leichman L, Nigro N, Vaitkevicius VK, et al：Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med 78：211-215, 1985

2）Epidermoid anal cancer：results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348：1049-1054, 1996

3）Northover J, Glynne-Jones R, Sebag-Montefiore D, et al：Chemoradiation for the treatment of epidermoid anal cancer：13-year follow-up of the first randomised UKCCCR Anal Cancer Trial（ACT Ⅰ）. Br J Cancer 102：1123-1128, 2010

4）Bartelink H, Roelofsen F, Eschwege F, et al：Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer：results of a phase Ⅲ randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15：2040-2049, 1997

5）Flam M, John M, Pajak TF, et al：Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal：results of a phase Ⅲ randomized intergroup study. J Clin Oncol 14：2527-2539, 1996

6）James RD, Glynne-Jones R, Meadows HM, et al：Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus（ACT Ⅱ）：a randomised, phase 3, open-label, 2×2 factorial trial. Lancet Oncol 14：516-524, 2013

7）Ajani JA, Winter KA, Gunderson LL, et al：Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal：a randomized controlled trial. JAMA 299：1914-1921, 2008

8）Gunderson LL, Winter KA, Ajani JA, et al：Long-term update of US GI intergroup RTOG 98-11 phase Ⅲ trial for anal carcinoma：survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 30：4344-4351, 2012

9）Glynne-Jones R, Meadows H, Wan S, et al：EXTRA—a multicenter phase Ⅱ study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 72：119-126, 2008

10）Ito Y, Hamaguchi T, Takashima A, et al：Definitive S-1/mitomycin-C chemoradiotherapy for stage Ⅱ/Ⅲ anal canal squamous cell carcinoma：a phase Ⅰ/Ⅱ dose-finding and single-arm confirmatory study（JCOG0903）. Int J Clin Oncol 28：1063-1072, 2023

11）Murofushi KN, Itasaka S, Shimokawa M, et al：A phase Ⅱ study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal（the JROSG 10-2 trial）. J Radiat Res 64：154-161, 2023

12）Tachibana I, Nishimura Y, Inada M, et al：Definitive chemoradiotherapy for anal canal cancer：single-center experience. Int J Clin Oncol 23：1121-1126, 2018

13）Kachnic LA, Winter KA, Myerson RJ, et al：Long-Term Outcomes of NRG Oncology/RTOG 0529：A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. Int J Radiat Oncol Biol Phys 112：146-157, 2022

14）Kim TH, Chie EK, Kim DY, et al：Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys 62：769-775, 2005

15）Kachnic LA, Winter K, Myerson RJ, et al：RTOG 0529：a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86：27-33, 2013

16）日本放射線腫瘍学会（編）：直腸癌・肛門癌 リンパ節領域アトラス．放射線治療計画ガイドライン2020年版．pp 224-227，金原出版，2020

17）日本医学物理学会，日本放射線技術学会，日本放射線腫瘍学会：強度変調放射線治療における物理技術ガイドライン2023．2023　https://www.jsmp.org/guidline/（2024年6月2日アクセス）

18）Yamada K, Shiraishi K, Takashima A, et al：Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan. Int J Clin Oncol 28：990-998, 2023

19）Glynne-Jones R, Sebag-Montefiore D, Meadows HM, et al：Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus（ACT Ⅱ）：a post-hoc analysis of randomised controlled phase 3 trial. Lancet Oncol 18：347-356, 2017